Lijie He

1.1k citations
21 papers · 709 indexed · h-index 12
Topics
RNA modifications and cancer (5 papers)Cancer-related molecular mechanisms research (4 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaGermanyAustralia

In The Last Decade

Lijie He

21 papers receiving 700 citations

Peers

Lijie He
Comparison fields: 5 of 88
  • Molecular Biology 502
  • Cancer Research 220
  • Oncology 106
  • Pulmonary and Respiratory Medicine 74
  • Surgery 65
Replace Martina Klünemann with:
Martina Klünemann Germany
Xinyu Shao China
J. Richard Brewer United States
Shuo Zeng China
Ruxian Lin United States
Maryann Kwa United States
Haixiang Sun China
Lydia Brandl Germany
Zhonghua Chu China
Shihui Li China
Lijie He relative to Martina Klünemann Germany Martina Klünemann's profile →
Citations per field
00.5×10×15×20×25×
Martina Klünemann · 1×
Citations per year

Countries citing papers authored by Lijie He

Since Specialization
Citations

This map shows the geographic impact of Lijie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijie He more than expected).

Fields of papers citing papers by Lijie He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijie He. The network helps show where Lijie He may publish in the future.

Co-authorship network of co-authors of Lijie He

This figure shows the co-authorship network connecting the top 25 collaborators of Lijie He. A scholar is included among the top collaborators of Lijie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijie He. Lijie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 5
3 13
4 28
5 100
6 53
7 20
8 18
9 4
10 7
11 2
12 3
13 5
14
Down-regulation of LINC00341 predicts a poor prognosis and acts as a tumor suppressor in gastric cancer.
2
15 11
16 5
17 31
18 84
19 155
20 55

About Lijie He

Lijie He is a scholar working on Cancer Research, Nephrology and Oncology, having authored 21 papers that have together received 709 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (220 citations), Molecular Biology (502 citations) and Biological Psychiatry (10 citations). Lijie He has collaborated with scholars based in China, Germany and Australia. Frequent co-authors include Xing‐Ming Zhao, Wei‐Hua Chen, Daiming Fan, Changcun Guo, Yongzhan Nie, Kaichun Wu, Xiaodi Zhao, Kang Ning, Die Dai and Sicheng Wu. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026